C. Geredeli Et Al. , "The Relationship Between Pathological Complete Response and Ki 67 İndex in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy: Retrospective Single Center Experience," 2. Ulusal İmmünoterapi ve Onkoloji Kongresi , no.5534083, Antalya, Turkey, 2018
Geredeli, C. Et Al. 2018. The Relationship Between Pathological Complete Response and Ki 67 İndex in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy: Retrospective Single Center Experience. 2. Ulusal İmmünoterapi ve Onkoloji Kongresi , (Antalya, Turkey).
Geredeli, C., Arici, S., Sakin, A., Yasar, N., & Cihan, S., (2018). The Relationship Between Pathological Complete Response and Ki 67 İndex in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy: Retrospective Single Center Experience . 2. Ulusal İmmünoterapi ve Onkoloji Kongresi, Antalya, Turkey
Geredeli, Caglayan Et Al. "The Relationship Between Pathological Complete Response and Ki 67 İndex in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy: Retrospective Single Center Experience," 2. Ulusal İmmünoterapi ve Onkoloji Kongresi, Antalya, Turkey, 2018
Geredeli, Caglayan Et Al. "The Relationship Between Pathological Complete Response and Ki 67 İndex in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy: Retrospective Single Center Experience." 2. Ulusal İmmünoterapi ve Onkoloji Kongresi , Antalya, Turkey, 2018
Geredeli, C. Et Al. (2018) . "The Relationship Between Pathological Complete Response and Ki 67 İndex in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy: Retrospective Single Center Experience." 2. Ulusal İmmünoterapi ve Onkoloji Kongresi , Antalya, Turkey.
@conferencepaper{conferencepaper, author={Caglayan Geredeli Et Al. }, title={The Relationship Between Pathological Complete Response and Ki 67 İndex in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy: Retrospective Single Center Experience}, congress name={2. Ulusal İmmünoterapi ve Onkoloji Kongresi}, city={Antalya}, country={Turkey}, year={2018}}